Поиск по каталогу |
(строгое соответствие)
|
- Профессиональная
- Научно-популярная
- Художественная
- Публицистика
- Детская
- Искусство
- Хобби, семья, дом
- Спорт
- Путеводители
- Блокноты, тетради, открытки
Counterfeit drugs: The demand side study in Sudan.
В наличии
Местонахождение: Алматы | Состояние экземпляра: новый |
Бумажная
версия
версия
Автор: Abubakr Alfadl
ISBN: 9783659557996
Год издания: 2014
Формат книги: 60×90/16 (145×215 мм)
Количество страниц: 296
Издательство: LAP LAMBERT Academic Publishing
Цена: 35948 тг
Положить в корзину
Способы доставки в город Алматы * комплектация (срок до отгрузки) не более 2 рабочих дней |
Самовывоз из города Алматы (пункты самовывоза партнёра CDEK) |
Курьерская доставка CDEK из города Москва |
Доставка Почтой России из города Москва |
Аннотация: Combating drug counterfeiting is a highly complex issue. While supply side of drugs counterfeiting received high attention in the literature, very little is known about the demand side especially in developing countries. In an attempt to contribute to this gap in the literature, this book demonstrates how a conceptual model can he developed to examine the demand side of counterfeit drugs phenomenon. Based on an accepted method of scale development in marketing research, a lengthy scale development process was undertaken to develop a consumer behaviour toward counterfeit drugs scale. Then the book suggests and validates a conceptual model that empirically investigates Sudanese consumers’ perspectives of their purchase intention of counterfeit drugs. Creation of this conceptual model aids a deeper understanding for the connections linking consumers’ perspectives about counterfeit drugs and their purchase intention by examining the association between attitude, subjective norm, motivation, and purchase intention in one single model. This book will add to existing literature on counterfeit drugs demand in developing countries theoretically, methodologically and managerially.
Ключевые слова: Developing countries, behaviour, Sudan, consumer, Counterfeit drugs